Breakthrough innovative rapid 3D bioprinting technology Roll Porous Scaffold
Problem and implemented solution
1) Parallel testing of new substances not on animals, but using generated 3D biomodels “organ on a chip” 2) Personalized medicine with simultaneous testing of multiple treatment methods and drugs, targeted therapy for a specific patient in vitro on the 3D composition of his personal cells and selection of the most effective with the lowest toxicity 3) Overcoming the shortage of organs for implantation and personal hormone replacement therapy for everyone using printed endocrine glands from their cells
Nomination
Biotechnology And National Health
Topic
Technologies for human health
Estimated duration of implementation
12 months (1year)
Implementation geography
Ulan-Ude, Buryatia, Russia
Description of competitive advantages
Roll Porous Scaffold fast 3D bioprinting technology is orders of magnitude superior to analogues
Simultaneous printing of >10 cell types (collagen and elastin, blood vessels, nerves and other tissues)
Size >10-15 microns
Density ~>1.26×10^8 cells/ml
Layer thickness ~18 microns
Productivity >1.7 l/hour
List of awards and prizes, media articles about the organization/individual or the Practice
https://www.scopus.com/authid/detail.uri?authorId=56536940900
List of scientific works and IP connected with the Practice
N.A.
